RECOMBITEK C4/CV

DESCRIPTION: RECOMBITEK® C4/CV contains a lyophilized suspension of a recombinant canarypox vector expressing the HA and F glycoproteins of canine distemper virus; modified live adenovirus type 2, parainfluenza virus, parvovirus, and coronavirus; plus sterile water diluent. Safety and immunogenicity of this product have been demonstrated by vaccination and challenge tests in susceptible dogs.

DOSAGE: Reconstitute the lyophilized vaccine with accompanying liquid diluent and aseptically inject 1 mL (1 dose) subcutaneously or intramuscularly into healthy dogs. For primary vaccination, revaccinate with a second 1 mL dose 2 to 3 weeks later. Dogs younger than 12 weeks of age should be revaccinated with a single 1 mL dose every 2 to 3 weeks, the last dose given at or over 12 weeks of age. Revaccinate annually with a single 1 mL dose.

PRECAUTIONS: Store at 2-7°C (35-45°F). Use immediately after reconstitution. Do not use chemicals to sterilize syringes and needles. Burn container and all unused contents. Contains gentamicin as a preservative. It is generally recommended to avoid vaccination of pregnant dogs. In rare instances, administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions. Transient lethargy, as well as pain and swelling at the site of injection, may occur following use of this product. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine, as directed by a veterinarian.

Every effort has been made to ensure the accuracy of the RECOMBITEK C4/CV information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.